Electrographic Flow (EGF)™ mapping with Ablamap® is a novel technique to create full temporospatial visualizations of organized action potential flow within the chaotic conduction of atrial fibrillation. Ablacon has built a premier machine intelligence system to quantitatively and qualitatively understand and treat atrial fibrillation.
Electrographic Flow™ mapping and ablation
Ablamap® reveals action potential flow
Electrographic Flow™ improves our understanding of Atrial Fibrillation
Phenomena revealed by Electrographic Flow mapping are related to the initiation and maintenance of AF.
Ablamap® is CE Marked and commercially available in the EU.
Ablamap® is not commercially available in the United States and limited to research use.